Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results.

Rathika KandasamyMarios ConstantinouSophie L RogersSukhpal Singh SandhuSanjeewa WickremasingheSalmaan Al-QureshiLyndell L Lim

Published in: The British journal of ophthalmology (2019)

When given as an adjunct to cataract surgery, both TA and BVB improved visual outcomes at 6 months postoperatively. However, only TA resulted in sustained improvement in CMT, with the majority not requiring any further treatment postoperatively.

Keyphrases

cataract surgery
clinical trial
open label
double blind
study protocol
type diabetes
phase ii
vascular endothelial growth factor
randomized controlled trial
wound healing
optical coherence tomography
age related macular degeneration
metabolic syndrome
phase iii
glycemic control